| Financial Year |
March 31 2023 |
| Monetary Funds |
108,509,351.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
104,923,306.29 |
| Advances to Suppliers |
12,746,607.79 |
| Other Receivables |
2,829,360.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
162,465,481.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
307,696,739.58 |
| Total Current Assets |
704,606,925.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,003,376.08 |
| Investment Properties |
-- |
| Fixed Assetes |
184,271,903.50 |
| Under-construction Projects |
9,461,701.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,493,817.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,086,333.21 |
| Deferred Income Tax Assets |
10,894,894.04 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
264,212,025.28 |
| Total Assets |
968,818,950.76 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
49,952,273.68 |
| Accounts Payable |
64,827,767.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,688,747.63 |
| Taxes Payable |
5,087,956.67 |
| Interest Payable |
-- |
| Dividend Payable |
217,500.00 |
| Other payables |
8,385,707.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,934,728.96 |
| Sub-Total of Current Liabilities |
160,349,281.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,632,028.31 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,453,414.91 |
| Total Liabilities |
178,802,696.25 |
| Paid-In Capital(Or Share Stock) |
152,244,000.00 |
| Capital Surplus |
269,667,617.66 |
| Surplus Reserve |
46,497,775.54 |
| LESS:Treasury Stock |
4,058,700.00 |
| Undistributed Profits |
303,755,596.01 |
| Minority Stockholder's Interest |
5,705,934.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
784,310,320.20 |
| Owner's Equity（Stockholder's Equity） |
790,016,254.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
968,818,950.76 |
